Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
year increase » linear increase (Expand Search), may increase (Expand Search)
Showing 2,221 - 2,240 results of 30,146 for search '(( significant decrease decrease ) OR ( significantly ((teer decrease) OR (year increase)) ))', query time: 0.68s Refine Results
  1. 2221
    Annual treatment frequencies in recurrence and non-recurrence groups.

    Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2222
    Additional loss of life expectancy and cost per life-year saved resulting from changes in colorectal cancer stage due to a 1-year diagnostic delay.

    Additional loss of life expectancy and cost per life-year saved resulting from changes in colorectal cancer stage due to a 1-year diagnostic delay. by Hiroaki Saito (24514)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 2223
    Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups.

    Time course of best-corrected visual acuity (BCVA) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 2224
    Preoperative background characteristics of the patients.

    Preoperative background characteristics of the patients. by Yasuyuki Sotani (20114144)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 2225
    Cost-effectiveness and health outcomes of increased monitoring of adults with HBeAg-negative inactive CHB and HBeAg-positive immune tolerant CHB to 90% and increased antiviral treatment to 80% when they become treatment eligible compared to current practice for a population of 100,000 adults with inactive or immune tolerant CHB.

    Cost-effectiveness and health outcomes of increased monitoring of adults with HBeAg-negative inactive CHB and HBeAg-positive immune tolerant CHB to 90% and increased antiviral trea... by Mehlika Toy (821862)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 2226
    The prevalence of urinary stones and rates among 20-54years in 1990 and 2021, and the trends from 1990 to 2021.

    The prevalence of urinary stones and rates among 20-54years in 1990 and 2021, and the trends from 1990 to 2021. by Weitao Yao (17523658)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 2227
    A depiction of areas significantly more activated in patients (blue) and controls (red) respectively during the psychomotor vigilance task performance.

    A depiction of areas significantly more activated in patients (blue) and controls (red) respectively during the psychomotor vigilance task performance. by Anna Holmqvist (20234646)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 2228
    Results for Obesity at 42 years old for individuals healthy/underweight at 16 years old (n = 4767, 27.192% of N).

    Results for Obesity at 42 years old for individuals healthy/underweight at 16 years old (n = 4767, 27.192% of N). by Glenna Nightingale (4806495)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 2229
    Data file without outliers.

    Data file without outliers. by Helena Wallin (6103205)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2230
    Kaplan–Meier curves for the primary outcome (A) and total mortality (B). The event-free survival time was significantly better in the positive reverse remodeling (PRR) group than in the negative reverse remodeling (NRR) group. (A) The mean (and 95% CI) survival times were 10.308 years (9.473–11.143) in the PRR group and 8.122 years (7.181–9.063) in the NRR group. The overall event-free survival mean for all patients was 9.290 years (8.636–9.994). (B) The mean (and 95% CI) survival times were 10.591 years (9.791–11.391) in the PRR group and 8.605 years (7.675–9.534) in the NRR group. The overall event-free survival mean for all patients was 9.695 years (9.060–10.329).

    Kaplan–Meier curves for the primary outcome (A) and total mortality (B). The event-free survival time was significantly better in the positive reverse remodeling (PRR) group than i... by Maria Tereza Sampaio de Sousa Lira (21169240)

    Published 2025
    Save to List
    Saved in:
  11. 2231
    Alterations of Ceramides, Acylcarnitines, GlyceroLPLs, and Amines in NSCLC Tissues

    Alterations of Ceramides, Acylcarnitines, GlyceroLPLs, and Amines in NSCLC Tissues by Jie Zhang (64655)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 2232
    The speed diagram.

    The speed diagram. by Yifei Li (198040)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 2233
    Factors of orthogonal experiment.

    Factors of orthogonal experiment. by Yifei Li (198040)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 2234
    Analysis of variance in orthogonal test.

    Analysis of variance in orthogonal test. by Yifei Li (198040)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 2235
    Comparison between simulation tests and bench tests.

    Comparison between simulation tests and bench tests. by Yifei Li (198040)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 2236
    Schematic diagram of the millet characteristic dimensions.

    Schematic diagram of the millet characteristic dimensions. by Yifei Li (198040)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 2237
    Structure and collision diagram of the millet hole seeding system.

    Structure and collision diagram of the millet hole seeding system. by Yifei Li (198040)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 2238
    Analysis of variance in orthogonal test.

    Analysis of variance in orthogonal test. by Yifei Li (198040)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 2239
    Comparison between simulation tests and bench tests.

    Comparison between simulation tests and bench tests. by Yifei Li (198040)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 2240
    Comparison between simulation tests and bench tests.

    Comparison between simulation tests and bench tests. by Yifei Li (198040)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: